{
  "actions": [
    {
      "acted_at": "2018-04-23",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2018-04-23",
      "action_code": "",
      "committees": [
        "SSFI"
      ],
      "references": [
        {
          "reference": "CR S2343-2346",
          "type": "text of measure as introduced"
        }
      ],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Finance.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s2729-115",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Finance",
      "committee_id": "SSFI"
    }
  ],
  "congress": "115",
  "cosponsors": [],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2018-04-23",
  "number": "2729",
  "official_title": "A bill to establish programs related to prevention of prescription opioid misuse, and for other purposes.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "hr5865-115",
      "identified_by": "CRS",
      "reason": "identical",
      "type": "bill"
    }
  ],
  "short_title": "Addiction Prevention and Responsible Opioid Practices Act",
  "sponsor": {
    "bioguide_id": "D000563",
    "district": null,
    "name": "Durbin, Richard J.",
    "state": "IL",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2018-04-23",
  "subjects": [
    "Alternative treatments",
    "Business ethics",
    "Business records",
    "Congressional oversight",
    "Drug safety, medical device, and laboratory regulation",
    "Drug therapy",
    "Drug trafficking and controlled substances",
    "Drug, alcohol, tobacco use",
    "Government information and archives",
    "Government studies and investigations",
    "Health",
    "Health care quality",
    "Health information and medical records",
    "Health personnel",
    "Health programs administration and funding",
    "Health promotion and preventive care",
    "Health technology, devices, supplies",
    "Hospital care",
    "Indian social and development programs",
    "Licensing and registrations",
    "Marketing and advertising",
    "Medical education",
    "Medical ethics",
    "Medicare",
    "Military medicine",
    "Minority health",
    "Prescription drugs",
    "Sales and excise taxes",
    "State and local government operations",
    "User charges and fees",
    "Veterans' medical care"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2018-04-23",
    "date": "2019-08-01T21:26:30Z",
    "text": "Addiction Prevention and Responsible Opioid Practices Act\n\nThis bill establishes a series of requirements relating to opioid regulation, prescribing, and monitoring, including licensure requirements for pharmaceutical representatives, a national opioid drug mapping tool to monitor prescribing practices of Medicaid providers, and an excise tax on opioid manufacturers."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Addiction Prevention and Responsible Opioid Practices Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to establish programs related to prevention of prescription opioid misuse, and for other purposes.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Addiction Prevention and Responsible Opioid Practices Act",
      "type": "short"
    }
  ],
  "updated_at": "2023-01-11T13:39:40Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/115/s/BILLSTATUS-115s2729.xml"
}